Potential benefits of ticagrelor plus aspirin in Chinese patients with stable coronary artery disease and diabetes

被引：0
|
作者：
Sun, W. [1 ]
Yan, B. [1 ]
机构：
[1] Chinese Univ Hong Kong, Hong Kong, Peoples R China
来源：
EUROPEAN HEART JOURNAL | 2021年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1218 / 1218
页数：1
相关论文
共 50 条
  • [41] Mortality Benefit of Rivaroxaban Plus Aspirin in Patients With Chronic Coronary or Peripheral Artery Disease
    Eikelboom, John W.
    Bhatt, Deepak L.
    Fox, Keith A. A.
    Bosch, Jacqueline
    Connolly, Stuart J.
    Anand, Sonia S.
    Avezum, Alvaro
    Berkowitz, Scott D.
    Branch, Kelley R. H.
    Dagenais, Gilles R.
    Felix, Camilo
    Guzik, Tomasz J.
    Hart, Robert G.
    Maggioni, Aldo P.
    Muehlhofer, Eva
    Sharma, Mukul
    Shestakovska, Olga
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (01) : 14 - 23
  • [42] Major Bleeding in Patients With Coronary or Peripheral Artery Disease Treated With Rivaroxaban Plus Aspirin
    Eikelboom, John W.
    Bosch, Jacqueline J.
    Connolly, Stuart J.
    Shestakovska, Olga
    Dagenais, Gilles R.
    Hart, Robert G.
    Leong, Darryl P.
    O'Donnell, Martin
    Fox, Keith A. A.
    Bhatt, Deepak L.
    Cairns, John A.
    Tasto, Christoph
    Berkowitz, Scott D.
    Bruns, Nancy Cook
    Muehlhofer, Eva
    Diaz, Rafael
    Maggioni, Aldo P.
    Yusuf, Salim
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 74 (12) : 1519 - 1528
  • [43] Aspirin Desensitization in Patients with Coronary Artery Disease
    Pui, Sim Pui
    Ning, Shirley Tan Siang
    Yip, Alan Fong Yean
    Kiam, Ong Tiong
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2018, 273 : 4 - 4
  • [44] Aspirin resistance in patients with coronary artery disease
    Walton, BL
    Civitello, AB
    Wilson, JM
    Allison, P
    Bracey, A
    Ferguson, JJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 335A - 335A
  • [45] Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease
    Campo, Gianluca
    Sega, Francesco Vieceli Dalla
    Pavasini, Rita
    Aquila, Giorgio
    Gallo, Francesco
    Fortini, Francesca
    Tonet, Elisabetta
    Cimaglia, Paolo
    Del Franco, Annamaria
    Pestelli, Gabriele
    Pecoraro, Alessandro
    Contoli, Marco
    Balla, Cristina
    Biscaglia, Simone
    Rizzo, Paola
    Ferrari, Roberto
    THROMBOSIS AND HAEMOSTASIS, 2017, 117 (06) : 1208 - 1216
  • [46] The stratification of platelet reactivity and activation in patients with stable coronary artery disease on aspirin therapy
    Gurbel, PA
    Bliden, KP
    THROMBOSIS RESEARCH, 2003, 112 (1-2) : 9 - 12
  • [47] Hypertension as a Risk Factor for Aspirin and Clopidogrel Resistance in Patients With Stable Coronary Artery Disease
    Akturk, Ibrahim Faruk
    Caglar, Fatma Nihan
    Erturk, Mehmet
    Tuncer, Nilgun
    Yalcin, Ahmet Arif
    Surgit, Ozgur
    Uzun, Fatih
    Caglar, Ilker Murat
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2014, 20 (07) : 749 - 754
  • [48] An updated drug profile of ticagrelor with considerations on the treatment of patients with coronary artery disease and diabetes mellitus
    Calderone, Dario
    Capodanno, Davide
    Angiolillo, Dominick J.
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2020, 18 (08) : 449 - 464
  • [49] Determinants of cyclooxygenase-1-inhibition with aspirin in patients with stable coronary artery disease
    Grove, E. L.
    Larsen, S. B.
    Neergaard-Petersen, S.
    Wurtz, M.
    Kristensen, S. D.
    Hvas, A. M.
    EUROPEAN HEART JOURNAL, 2014, 35 : 1168 - 1169
  • [50] Treatment with aspirin and clopidogrel inhibit thrombin generation in patients with stable coronary artery disease
    Bandi, A.
    Mosialos, L.
    Katsiki, N.
    Zarifis, J.
    Vassara, C.
    Kaprinis, I
    Kiskinis, D.
    Elalamy, I
    Gerotziafas, G. T.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 586 - 586
12345